Sosei Collaborates With GSK On Immune Disorders Of Digestive System; Eligible To Receive Up $481 Mln
(RTTNews) - Japan's Sosei Group Corp said that it has reached a global collaboration and license agreement with GlaxoSmithKline Plc (GSK.L, GSK) targeting immune disorders of the digestive system in a ...
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) announced today a multi-year collaboration with GSK on the development of a next-generation equipment design, building upon Pfizer’s existing portable ...
Earlier this year, we projected that 2021 would be the year of quantum computing for drug discovery, positing the idea that this is one of only a few areas where there is big ROI to offset the work ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results